Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-8.34 %
$ 70.1 M
Market Cap
0.07
P/E
AVTX - OPERATING EXPENSES
Operating Expenses AVTX - Avalo Therapeutics, Inc.
640 K
LAST VALUE
-91.38%
2 YEAR CAGR
-53.53%
5 YEAR CAGR
-25.96%
10 YEAR CAGR